Your browser doesn't support javascript.
loading
Expression and significance of Survivin mRNA in xenotransplanted nasopharyngeal carcinoma treated by paclitaxel combined with radiotherapy / 临床耳鼻咽喉头颈外科杂志
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 796-799, 2009.
Article in Chinese | WPRIM | ID: wpr-748650
ABSTRACT
OBJECTIVE@#To investigate the expression and significance of Survivin mRNA in xenotransplanted nasopharyngeal carcinoma treated by paclitaxel combined with radiotherapy.@*METHOD@#Xenotransplanted nasopharyngeal carcinoma was established by CNE-2 cell line, then grouped and treated with paclitaxel, radiotherapy, paclitaxel combined with radiotherapy respectively. Xenotransplanted tumor volume was measured; tumor specimens were confirmed by routine hemotoxylin-eosin staining; apoptosis index was assayed by flow cytometry and Survivin mRNA was detected by one step RT-PCR.@*RESULT@#Xenotransplanted tumor growth was significantly inhibited by paclitaxel combined with radiotherapy and its inhibition rate was 99.3%. Compared to control group, apoptosis index was apparently increased in the other three groups (P0.05).@*CONCLUSION@#Paclitaxel combined with radiotherapy can induce significant killing effect in xenotransplanted nasopharyngeal carcinoma; paclitaxel can enhance the radiosensitivity of xenotransplanted nasopharyngeal carcinoma and its mechanism may rely on the down-regulation of Survivin expression.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Repressor Proteins / Therapeutics / Brachytherapy / RNA, Messenger / Nasopharyngeal Neoplasms / Paclitaxel / Xenograft Model Antitumor Assays / Cell Line, Tumor / Therapeutic Uses / Inhibitor of Apoptosis Proteins Type of study: Prognostic study Limits: Animals / Humans Language: Chinese Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery Year: 2009 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Repressor Proteins / Therapeutics / Brachytherapy / RNA, Messenger / Nasopharyngeal Neoplasms / Paclitaxel / Xenograft Model Antitumor Assays / Cell Line, Tumor / Therapeutic Uses / Inhibitor of Apoptosis Proteins Type of study: Prognostic study Limits: Animals / Humans Language: Chinese Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery Year: 2009 Type: Article